At IBT Bioservices, we specialize in providing comprehensive preclinical ELISA testing services to support research, drug development, and diagnostic applications. ELISA is a widely used immunoassay technique that allows for the detection and quantification of target analytes, such as proteins, antibodies, hormones, cytokines, and small molecules, with high sensitivity and specificity.
At IBT Bioservices, we pride ourselves on delivering high quality ELISA testing services. We understand the importance of accuracy, speed, and customization in research. Our team has over 15 years of experience with Immunoassays and ensures that every ELISA we perform meets the highest standards for research, clinical development, and drug discovery. Our commitment to customer satisfaction and tailored ELISA testing solutions makes us a trusted partner for all your clinical and preclinical research needs.
Serology testing is essential for evaluating the potential immune responses elicited by therapeutic proteins, biologics, and vaccines. We provide ELISA-based serology assays to detect and quantify the presence of anti-drug antibodies (ADAs) in biological samples. Our immunogenicity testing helps assess the immunogenic potential of therapeutic agents, identify potential adverse reactions, and support regulatory submissions.
At IBT Bioservices, we ensure a streamlined process from assay development to data delivery. Here’s how we work:
Consultation: We understand your project goals and specific assay requirements.
Development: We develop or customize your ELISA to fit your needs.
Validation: If required, our team will follow our rigorous validation processes to ensure the reliability and reproducibility of your results.
Sample Analysis: Your samples undergo analysis with high-quality reagents and calibrated equipment.
Data Reporting: You receive a comprehensive data report, including quantitative results and interpretation.
Our ELISA testing services support research involving multiple pathogens, including but not limited to:
We use standardized viral antigens to provide accurate and reliable test results, contributing to impactful virology research and therapeutic developments.
ELISA can be utilized to determine the pharmacokinetic profiles of therapeutic agents in preclinical studies. We offer ELISA-based PK assays to measure drug concentrations in various matrices, including plasma, serum, and urine. Our PK studies provide critical data on drug absorption, distribution, metabolism, and elimination, helping to optimize dosing regimens and assess drug bioavailability.
ELISA-based cytokine profiling allows for the simultaneous measurement of multiple cytokines and growth factors in biological samples. We offer cytokine profiling panels tailored to specific research needs, enabling the comprehensive evaluation of immune responses, inflammation, and disease progression. Our cytokine profiling assays provide valuable insights into the complex interplay of cytokines and their roles in various physiological and pathological processes.
Quantitative ELISA: Used to measure the precise concentration of specific analytes in biological samples with high sensitivity.
Competitive ELISA: Ideal for detecting small molecules and analytes in competitive binding scenarios.
Sandwich ELISA: Uses an antibody coated plate and a screening antigen.
Pathogen Specific ELISA: Optimized assays for detecting pathogen specific antibodies.
Our team of scientists and technicians are highly skilled and experienced in conducting HAI assays, ensuring accurate and reliable results.
We understand the unique needs of each research project and provide customized assay designs to meet your specific requirements.
We prioritize efficiency without compromising on quality. Our streamlined processes and advanced equipment allow for quick turnaround times, ensuring you receive results promptly.
We maintain rigorous quality control measures throughout our operations, ensuring the accuracy and reproducibility of our assay results.
Our dedicated customer support team is always available to address your queries and provide assistance at every step of the process.
How many samples can I test?
We can accommodate a wide range of sample sizes, from small-scale research projects to large-scale studies. Our high-throughput ELISA platforms allow us to handle up to thousands of samples efficiently.
What is your ELISA validation process?
We follow a rigorous validation process, including sensitivity, specificity, dilutional linearity and reproducibility testing. Each ELISA assay is validated according to ICHstandards to ensure reliability.
How do I ship my samples?
Samples should be shipped in appropriate conditions, usually on dry ice, to maintain sample integrity. Detailed shipping instructions and a Compound Submission Form will be provided upon project initiation.
How much does it cost for an ELISA test?
ELISA testing costs vary based on the complexity of the assay, number of samples, and customizations required. Contact us for a tailored quote at services@ibtbioservices.com
How accurate is the ELISA test?
Our ELISA assays are developed with high sensitivity and specificity, providing highly accurate quantification of analytes. Our team can provide statistical support as needed as well.
What is the difference between ELISA and EIA?
ELISA (Enzyme-Linked Immunosorbent Assay) and EIA (Enzyme Immunoassay) are similar techniques, but ELISA specifically refers to immunosorbent assays that use enzymes to detect antigen-antibody interactions. ELISA is typically more specific and quantitative.
This assay tests for hemagglutinin (HA)-specific antibodies against influenza virus (INFV). Serial dilutions of the TA starting are incubated with a standardized amount of IFV antigen and Turkey Red Blood Cells (TRBCs) in 96-well plates. In the absence of antibodies against influenza hemagglutinin (HA) glycoprotein, the HA protein agglutinates TRBCs. Hemagglutination is inhibited in the presence of HA-specific antibodies, which will bind to the antigenic sites on the HA protein. The number of antibodies present in a sample is quantified as an HA titer, given as the highest dilution of serum that completely inhibits hemagglutination. IBT’s method is standardized to the WHO testing protocol and can use live virus for testing.
.